27.25
price up icon2.14%   0.57
after-market After Hours: 27.25
loading
Staar Surgical Co stock is traded at $27.25, with a volume of 867.61K. It is up +2.14% in the last 24 hours and down -1.62% over the past month. Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$26.68
Open:
$26.87
24h Volume:
867.61K
Relative Volume:
0.55
Market Cap:
$1.34B
Revenue:
$224.45M
Net Income/Loss:
$-95.27M
P/E Ratio:
-14.12
EPS:
-1.93
Net Cash Flow:
$-43.74M
1W Performance:
+1.57%
1M Performance:
-1.62%
6M Performance:
+62.30%
1Y Performance:
-13.79%
1-Day Range:
Value
$26.69
$27.33
1-Week Range:
Value
$25.97
$27.33
52-Week Range:
Value
$13.50
$33.28

Staar Surgical Co Stock (STAA) Company Profile

Name
Name
Staar Surgical Co
Name
Phone
(626) 303-7902
Name
Address
1911 WALKER AVE, MONROVIA, CA
Name
Employee
1,211
Name
Twitter
@visianicl
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
STAA's Discussions on Twitter

Compare STAA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
STAA
Staar Surgical Co
27.25 1.32B 224.45M -95.27M -43.74M -1.93
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
435.73 154.00B 9.15B 2.63B 1.99B 7.1661
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
186.66 53.47B 21.39B 1.61B 2.55B 5.5609
Medical Instruments & Supplies icon
RMD
Resmed Inc
273.01 39.70B 5.15B 1.40B 1.65B 9.5082
Medical Instruments & Supplies icon
ALC
Alcon Inc
72.60 35.62B 10.03B 1.07B 1.39B 2.1549
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
262.47 18.82B 2.96B 487.70M 344.00M 6.6758

Staar Surgical Co Stock (STAA) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-21-25 Initiated Wells Fargo Equal Weight
Feb-12-25 Downgrade BTIG Research Buy → Neutral
Feb-12-25 Downgrade Jefferies Buy → Hold
Feb-12-25 Downgrade Mizuho Outperform → Neutral
Feb-12-25 Downgrade William Blair Outperform → Mkt Perform
Jul-15-24 Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-11-24 Upgrade BTIG Research Neutral → Buy
Mar-11-24 Upgrade Stifel Hold → Buy
Dec-05-23 Downgrade Needham Buy → Hold
Dec-04-23 Initiated Morgan Stanley Equal-Weight
Sep-15-23 Downgrade The Benchmark Company Buy → Hold
Aug-03-23 Downgrade Canaccord Genuity Buy → Hold
Jun-07-23 Downgrade William Blair Outperform → Mkt Perform
Apr-17-23 Initiated Piper Sandler Neutral
Feb-06-23 Downgrade BTIG Research Buy → Neutral
Dec-28-22 Reiterated BTIG Research Buy
Dec-08-22 Initiated Stifel Hold
Nov-07-22 Upgrade Sidoti Neutral → Buy
Oct-14-22 Resumed Stephens Overweight
Oct-13-22 Initiated Mizuho Buy
Apr-08-22 Initiated Needham Buy
Mar-28-22 Upgrade The Benchmark Company Hold → Buy
Mar-18-22 Upgrade BTIG Research Neutral → Buy
Jul-09-21 Initiated Oppenheimer Perform
Jan-19-21 Downgrade The Benchmark Company Buy → Hold
Oct-26-20 Downgrade Sidoti Buy → Neutral
Aug-31-20 Upgrade Sidoti Neutral → Buy
Aug-06-20 Reiterated The Benchmark Company Buy
Jul-06-20 Downgrade Sidoti Buy → Neutral
Jun-24-20 Downgrade BTIG Research Buy → Neutral
Jun-15-20 Initiated Jefferies Buy
Dec-04-19 Initiated BTIG Research Buy
Sep-24-18 Reiterated The Benchmark Company Buy
Aug-06-18 Resumed The Benchmark Company Buy
Nov-20-17 Reiterated The Benchmark Company Buy
Aug-14-17 Reiterated The Benchmark Company Buy
Mar-03-17 Reiterated The Benchmark Company Buy
May-18-16 Upgrade The Benchmark Company Hold → Buy
Sep-10-13 Resumed The Benchmark Company Buy
Feb-28-13 Reiterated The Benchmark Company Buy
Nov-01-12 Downgrade Canaccord Genuity Buy → Hold
Mar-02-12 Initiated Northland Securities Outperform
Oct-25-11 Reiterated The Benchmark Company Buy
Oct-12-10 Initiated Morgan Joseph Buy
May-11-10 Initiated Benchmark Buy
View All

Staar Surgical Co Stock (STAA) Latest News

pulisher
11:50 AM

Large Staar Holders Oppose $1.5B Sale - Orange County Business Journal

11:50 AM
pulisher
Oct 12, 2025

Broadwood slams STAAR board over “carelessness” in Alcon sale defense By Investing.com - Investing.com Canada

Oct 12, 2025
pulisher
Oct 11, 2025

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates STAA, GES, SMLR on Behalf of Shareholders - GlobeNewswire Inc.

Oct 11, 2025
pulisher
Oct 10, 2025

Investor Group Opposes Alcon's Acquisition of STAAR Surgical (AL - GuruFocus

Oct 10, 2025
pulisher
Oct 10, 2025

Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale - TipRanks

Oct 10, 2025
pulisher
Oct 10, 2025

Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale - MarketScreener

Oct 10, 2025
pulisher
Oct 10, 2025

Will STAAR Surgical Company benefit from macro trendsWeekly Trend Summary & Stock Portfolio Risk Management - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

STAAR Surgical holders should vote against sale to Alcon, Glass Lewis says - MSN

Oct 10, 2025
pulisher
Oct 09, 2025

Global Myopia Treatment Devices Market Poised for Strong Growth at a CAGR of ~8% by 2032, Driven by Technological Innovations and Increasing Eye Care Demand | DelveInsight - GlobeNewswire

Oct 09, 2025
pulisher
Oct 09, 2025

Glass Lewis recommends against STAAR–Alcon merger, bolstering Broadwood’s campaign - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Live market analysis of STAAR Surgical CompanyMarket Movers & Real-Time Chart Breakout Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

STAAR Surgical (STAA): A Fresh Look at Valuation Following Recent Share Price Cooldown - simplywall.st

Oct 08, 2025
pulisher
Oct 08, 2025

Glass Lewis Issues Recommendations to Shareholders of STAAR Surgical Company - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

STAAR Surgical Board Defends $1.5 Billion Alcon Acquisition Plan - Finimize

Oct 08, 2025
pulisher
Oct 08, 2025

AI Insurance Is Expensive - Bloomberg.com

Oct 08, 2025
pulisher
Oct 08, 2025

Alcon (ALC) Faces Opposition in Staar Surgical Merger Deal - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

STAAR urges shareholders to approve Alcon merger despite Glass Lewis report - Investing.com India

Oct 08, 2025
pulisher
Oct 08, 2025

STAAR Surgical (STAA): Proxy Adviser Urges Rejection of Alcon De - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Glass Lewis Advises Against Alcon (ALC) Acquisition of STAAR - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

STAAR Surgical Provides Information to Shareholders - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon - MarketScreener

Oct 08, 2025
pulisher
Oct 07, 2025

Defender Capital Opposes STAAR Surgical's Proposed Acquisition By Alcon - Nasdaq

Oct 07, 2025
pulisher
Oct 07, 2025

Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon - Stock Titan

Oct 07, 2025
pulisher
Oct 07, 2025

STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company - Stocktwits

Oct 07, 2025
pulisher
Oct 07, 2025

STAAR shareholders urged to vote for Alcon merger with 59% premium - Investing.com Canada

Oct 07, 2025
pulisher
Oct 06, 2025

Yunqi Capital opposes sale of STAAR Surgical to Alcon - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Yunqi Capital opposes sale of STAAR Surgical to Alcon By Investing.com - Investing.com Nigeria

Oct 06, 2025
pulisher
Oct 06, 2025

Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon - The Joplin Globe

Oct 06, 2025
pulisher
Oct 06, 2025

$62/Share Offer Challenged: STAAR Shareholder Yunqi (5.1%) Reiterates Opposition Ahead of Vote - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

STAAR Surgical Faces Shareholder Clash Over Alcon Buyout - Finimize

Oct 06, 2025
pulisher
Oct 06, 2025

Broadwood urges STAAR shareholders to reject $28 per share Alcon deal - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Broadwood urges shareholders to vote against proposed acquisition of STAAR by Alcon - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis - Business Wire

Oct 06, 2025
pulisher
Oct 06, 2025

59% premium to 90-day VWAP: STAAR Surgical backs $28 Alcon merger and urges stockholders to vote - Stock Titan

Oct 06, 2025
pulisher
Oct 04, 2025

Major STAAR Surgical Investors Push Back On Alcon Acquisition - Finimize

Oct 04, 2025
pulisher
Oct 04, 2025

STAAR Surgical (STAA): Evaluating Valuation Following Recent Share Price Surge - Yahoo

Oct 04, 2025
pulisher
Oct 03, 2025

Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - GlobeNewswire

Oct 03, 2025
pulisher
Oct 03, 2025

Why STAAR Surgical Company stock could rally in 2025Earnings Recap Summary & Daily Entry Point Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

27.5% Holder Broadwood Releases 81-Page Brief Urging STAAR Surgical Vote Against Alcon Deal - Stock Titan

Oct 03, 2025
pulisher
Oct 03, 2025

How hedge fund analytics apply to STAAR Surgical Company stockWeekly Market Report & Safe Capital Preservation Plans - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Comparing STAAR Surgical Company in custom built stock radarsTrade Performance Summary & Comprehensive Market Scan Reports - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

BUYOUT INVESTIGATION: Does $28.00 Per Share Buyout Offer Shortchange STAAR Surgical Company (NASDAQ: STAA) Shareholders? Kaskela Law LLC is Investigating the Buyout Offer and Encourages STAA Shareholders to Contact the Firm - PR Newswire

Oct 01, 2025
pulisher
Oct 01, 2025

Combining price and volume data for STAAR Surgical CompanyTrade Analysis Report & Community Consensus Trade Alerts - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Alcon, STAAR Surgical see US antitrust waiting period expire - MLex

Sep 30, 2025
pulisher
Sep 30, 2025

Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

$1.5B Eye Care Merger Progresses: Alcon's Premium Buyout of STAAR Surgical Clears Key Regulatory Hurdle - Stock Titan

Sep 30, 2025
pulisher
Sep 29, 2025

Broadwood files definitive proxy, STAAR reaffirms Alcon merger - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

Broadwood files definitive proxy, STAAR reaffirms Alcon merger By Investing.com - Investing.com UK

Sep 29, 2025
pulisher
Sep 29, 2025

Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance (NYSE:ALC) - Seeking Alpha

Sep 29, 2025

Staar Surgical Co Stock (STAA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$13.78
price up icon 2.84%
medical_instruments_supplies BAX
$22.11
price up icon 0.73%
$70.88
price up icon 0.51%
medical_instruments_supplies COO
$69.30
price up icon 1.36%
$65.51
price down icon 3.32%
medical_instruments_supplies WST
$262.47
price up icon 0.27%
Cap:     |  Volume (24h):